March 29, 2026

Pharma

1764050811 untitled design 54.jpg

Pharma talks: Piyush Goyal meets stakeholders to push innovation; firms confident as sector stays unfazed by US tariff threat

contact@dailyupdatesindia.com02 mins

Piyush Goyal meets Pharma stakeholders to push innovation (Picture credit: X/@PiyushGoyal) Union minister of commerce and industry, Piyush Goyal, held a key interaction with stakeholders from India’s pharmaceutical sector, focusing on strengthening industry growth and regulatory reforms. The minister highlighted discussions on innovation, data protection frameworks, investment commitments, and opportunities to scale manufacturing in India.In…

Read More
1763130211 unnamed file.jpg

Trade push: India seeks faster Russian clearances as both sides target $100 bn by 2030; pharma and marine approvals on priority

contact@dailyupdatesindia.com02 mins

India has asked Russia to fast-track approvals for Indian exporters –including expedited listing of domestic establishments and quicker registration of marine and pharmaceutical products — as part of a broader push to expand two-way trade, the commerce ministry said on Thursday.Commerce secretary Rajesh Agrawal, currently in Moscow, stressed the need for “confidence-building measures to unlock…

Read More
Article 10.jpg

$100 billion trade target by 2030: India, Russia discuss ways to boost bilateral ties; marine and pharma products in focus

contact@dailyupdatesindia.com02 mins

AI image used for representative purposes India has urged Russia to expedite the approval of domestic establishments and registration of marine and pharmaceutical products to further strengthen bilateral trade ties.During his visit to Moscow, Commerce Secretary Rajesh Agrawal highlighted opportunities for expanding trade and proposed measures to improve market access, the commerce ministry said in…

Read More
1762606518 unnamed file.jpg

Pharma takeover: Pfizer set to acquire Metsera in $10 bn deal; wins board backing after Novo Nordisk exits bidding war

contact@dailyupdatesindia.com02 mins

Pfizer is poised to acquire US-based biotechnology firm Metsera in a $10 billion deal, after winning a heated bidding battle against Danish drugmaker Novo Nordisk, which has now withdrawn from the race, AFP reported.Metsera, which specialises in obesity treatments, said in a statement that Pfizer’s improved offer of $86.25 per share had been unanimously approved…

Read More
1762436071 unnamed file.jpg

Pharma growth: AstraZeneca profit surges 77% to $2.53 bn in Q3; US expansion and cancer drugs power strong results

contact@dailyupdatesindia.com02 mins

AstraZeneca reported a sharp rise in quarterly profit on Thursday, with strong US growth and robust sales of cancer drugs driving a 77% year-on-year jump in net earnings to $2.53 billion for the third quarter.The British pharmaceutical major said group revenue grew 12% to $15.2 billion, led by oncology treatments that now account for nearly…

Read More
1762095139 unnamed file.jpg

US tariffs hit India’s export engine: GTRI report shows 37.5% slump across key sectors; smartphones, pharma, gems among worst hit

contact@dailyupdatesindia.com03 mins

India’s exports to the US plunged 37.5% between May and September 2025 as sweeping tariff hikes by the Trump administration squeezed margins across major sectors, according to a report by India-based trade think tank Global Trade Research Initiative (GTRI), ANI reported.The US, India’s largest export market, saw shipments fall from $8.8 billion to $5.5 billion…

Read More
Sterile bioreactor inspection.jpg

Indian pharma eyes Russian market; Firms explore localised production; target to build largest API hub

contact@dailyupdatesindia.com02 mins

Indian pharmaceutical companies are increasingly setting their sights on the Russian market, exploring opportunities to establish production facilities across various regions there. This development was highlighted by Sergey Cheremin, Moscow Government Minister and Head of the Department for External Economic and International Relations, during the “TIME: Russia-India. Mutual Efficiency” forum.Cheremin revealed that productive negotiations are…

Read More
1760197030 unnamed file.jpg

Pharma expansion: Natco to acquire major stake in South Africa’s Adcock Ingram, firm to go private

contact@dailyupdatesindia.com03 mins

India’s Natco Pharma will acquire significant stakes in South African pharmaceutical giant Adcock Ingram in a deal valued at R4.2 billion, paving the way for the 135-year-old firm to become a privately held entity jointly owned by Natco and Bidvest, which will remain the majority shareholder.The decision followed a meeting of Adcock Ingram shareholders that…

Read More